Pharma news
Pharma
The European Medicines Agency has announced plans to temporarily further scale back and suspend activities in order to cope with a more significant staff loss from the agency’s relocation than was originally expected. 2 August 2018
Americas
The US Court of Appeals for the Federal Circuit has ordered the Patent Trial and Appeal Board to reconsider its assessments in three inter partes reviews, in the wake of the US Supreme Court’s SAS Institute v Iancu decision. 1 August 2018
Americas
Generic drug maker Amneal has secured a finding of non-infringement in a Hatch-Waxman case over kidney disease drug Sensipar (cinacalcet hydrochloride). 1 August 2018
Americas
Morgan Lewis & Bockius has boosted its IP litigation team with the addition of seven partners from McDermott Will & Emery who have experience in the life sciences and technology industries. 1 August 2018
Americas
US-based pharmaceutical company Pfizer today reported an increase in year-on-year revenue for the second quarter but projected nearly a $2 billion loss in 2018 due to patent expirations. 31 July 2018
Pharma
IP service provider Questel has acquired France-based Expernova, a company specialising in scientific big data. 30 July 2018
Americas
Sandoz has agreed to postpone its generic version of a cataract surgery drug made by biopharmaceutical company Omeros, ending a patent infringement lawsuit between the two in Delaware. 30 July 2018
Americas
Vanessa Yen has joined King & Spalding's trial and global disputes practice group as a partner after leaving Paul Hastings. 30 July 2018
Asia
In India, a non-profit organisation and an advocacy group have united to take on a patent covering pibrentasvir, part of the drug combination that forms AbbVie’s hepatitis C product Mavyret. 26 July 2018
Pharma
Earlier today, the Court of Justice of the European Union clarified when a product is ‘protected by a basic patent’ within the meaning of article 3(a) of the SPC regulation. 25 July 2018